SCHEMBL1205883

SCHEMBL1205883

COc1cc(C(C)(C)c2ccccc2)cc(OC)c1-c1cccc(C)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 9/20 0.65
CNR1 P21554 5/20 0.65
SMN1; SMN2 Q16637 4/20 0.39
ALDH1A1 P00352 3/20 0.39
HSD17B10 Q99714 3/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
HPGD P15428 3/20 0.39
TP53 P04637 2/20 0.39
MEN1 O00255 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
KMT2A Q03164 1/20 0.39
RELA Q04206 1/20 0.39
PTPN5 P54829 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TSHR P16473 3/20 0.37
KDM4E B2RXH2 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1206635 0.83 CNR2 (0.68) CNR2CNR1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL1205807 0.79 CNR2 (1.00) CNR2CNR1SMN1; SMN2ALDH1A1NPC1
SCHEMBL1205244 0.79 CNR2 (0.63) CNR2CNR1ALDH1A1
SCHEMBL31545530 0.79 CNR2 (1.00) CNR2CNR1SMN1; SMN2ALDH1A1NPC1
SCHEMBL5461153 0.77 HTR1A (0.51) CNR2SMN1; SMN2ALDH1A1HSD17B10NPC1
SCHEMBL11639123 0.76 ESR1 (0.52) CNR2CNR1ALDH1A1TP53MEN1
SCHEMBL10417160 0.73 CNR1 (0.62) CNR2CNR1ALDH1A1PTPN5CYP2C9
SCHEMBL25940070 0.73 CNR2 (0.62) CNR2CNR1SMN1; SMN2ALDH1A1NPC1
SCHEMBL1206379 0.72 CNR2 (0.66) CNR2CNR1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL1207121 0.72 CNR2 (0.85) CNR2CNR1HSD17B10NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139546-B2 Tri-aryl/heteroaromatic cannabinoids and use thereof THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2015-09-22 US disclosed
EP-2131655-B1 TRI-ARYL/HETEROAROMATIC CANNABINOIDS AND USE THEREOF UNIV TENNESSEE RES FOUNDATION (US) 2014-05-07 EP disclosed
US-20110207748-A1 Tri-Aryl/Heteroaromatic Cannabinoids and Use Thereof THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-08-25 US disclosed
US-7888365-B2 Tri-aryl/heteroaromatic cannabinoids and use thereof THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2011-02-15 US disclosed
EP-2131655-A2 TRI-ARYL/HETEROAROMATIC CANNABINOIDS AND USE THEREOF The University of Tennessee Research Foundation (US) 2009-12-16 EP disclosed
US-20080234293-A1 Tri-aryl/heteroaromatic cannabinoids and use thereof THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2008-09-25 US disclosed
WO-2008109027-A2 TRI-ARYL/HETEROAROAROMATIC CANNABINOIDS AND USE THEREOF UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE (US) 2008-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234293-A1 Tri-aryl/heteroaromatic cannabinoids and use thereof CNR1, CNR2, OPRM1 CNR2 2/4885CNR1 1/4885SMN1; SMN2 4721/4885
US-20110207748-A1 Tri-Aryl/Heteroaromatic Cannabinoids and Use Thereof CNR1, CNR2, OPRM1 CNR2 2/4885CNR1 1/4885SMN1; SMN2 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.